Institutional & Family Asset Management, LLC Intellia Therapeutics, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$31.62 - $45.78 $189 - $274	6 Added 120.0%	11 $0
Q3 2021 Nov 10, 2021	SELL	$132.37 - $176.78 $397 - $530	-3 Reduced 37.5%	5 $1,000
Q2 2021 Aug 10, 2021	BUY	$60.88 - $161.91 $487 - $1,295	8 New	8 $1,000

Others Institutions Holding NTLA

# of Institutions

317

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$135 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$106 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$105 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$56.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$54.4 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $835M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account